<DOC>
	<DOCNO>NCT01178671</DOCNO>
	<brief_summary>The overall goal study examine efficacy combination mirtazapine sertraline treatment posttraumatic stress disorder ( PTSD ) . Sertraline FDA-approved PTSD , often fully effective . The combination mirtazapine serotonin reuptake inhibitor like sertraline appear highly effective related disorder -- depression . In study , sixty patient chronic PTSD randomize treatment either sertraline + mirtazapine sertraline + placebo 12 week . Patients show least minimal response 12 week continue another 12 week treatment .</brief_summary>
	<brief_title>Combined Mirtazapine SSRI Treatment PTSD : A Placebo-Controlled Trial</brief_title>
	<detailed_description>This double-blind randomized control trial conduct January 2011 February 2014 . To acquire diverse sample , outpatient recruit academic medical center private mental health clinic primarily Spanish-speaking patient . A single team investigator conduct trial setting . Individuals chronic PTSD randomly assign 24 week double-blind treatment sertraline plus mirtazapine sertraline plus placebo . This study conduct compliance Code Ethics World Medical Association ( Declaration Helsinki ) standard establish Institutional Review Board National Institutes Health . Informed consent obtain participant nature procedure explain . Participants Participants adult age 18-75 , refer clinician respond advertisement . After preliminary telephone screening , eligibility determine clinical interview confirm structured interview train raters use Clinician-Administered PTSD Scale ( CAPS ) Structured Clinical Interview DSM-IV Axis I Disorders -- Patient Edition . Participants principal Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSM-IV ) diagnosis chronic PTSD least moderate severity ( CAPS score â‰¥50 ) , English Spanish fluency . Bilingual clinician treat assessed individual Spanish language preference . Exclusion criterion significant suicidal ideation ; lifetime psychotic disorder , bipolar disorder , organic mental disorder , seizure disorder ; alcohol substance use disorder past 3 month ; unstable medical illness ; history traumatic brain injury great moderate severity ; pregnancy nursing ; unwillingness use contraception ( woman childbearing potential ) ; prior nonresponse sertraline combine treatment , intolerance sertraline mirtazapine ) ; psychotropic medication use prior 2 week ( 4 week monoamine oxidase inhibitor fluoxetine ) , except zolpidem insomnia allow three time per week week prior randomization ; psychotherapy initiate within 3 month randomization . Concomitant psychotropic medication permit study . Randomization Blinding Randomization use randomly permute block stratify patient language preference ( English vs. Spanish ) , implement data manager patient contact . Mirtazapine 15 mg capsule match placebo capsule package pharmacist patient contact . Patients remind visit independent evaluator ( IE ) discuss medication adverse event , allocation conceal research personnel throughout patient 's participation . Treatments A single psychiatrist saw patient medication management , initial visit 45 minute subsequent 30 minute visit weekly two week , biweekly week 12 , 4-week interval . At visit psychiatrist assess clinical improvement adverse event . Mirtazapine/placebo initiate 30 mg ( two capsule ) bedtime four week , patient without significant adverse event persistent PTSD symptom dose increase maximum 45 mg/day . Dose could decrease intolerable adverse event , minimum 15mg/day . Sertraline initiate 25 mg/day four day , increase tolerated 50 mg/day remainder Week 1 , 100 mg/day Weeks 2-4 , 150 mg/d Weeks 5-6 , 200 mg/day . Dosage could decrease clinically indicate minimum 50 mg/day . Compliance assess patient diary pill count . Patients prematurely discontinue study medication encourage return assessment week 24 .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Current primary diagnosis chronic PTSD Fluent English Spanish Past current schizophrenia , schizoaffective disorder , organic mental disorder , bipolar disorder , antisocial personality disorder . Substance abuse dependence diagnosis past 3 month Suicidal ideation behavior past 6 month pose significant danger . Medical illness could significant increase risk sertraline mirtazapine treatment assessment response History traumatic brain injury great mild severity History seizure disorder ( except febrile seizure childhood ) Currently take medication effective patient 's PTSD . Inability tolerate unwillingness accept drugfree period prior begin study certain psychiatric medication . History inability tolerate sertraline mirtazapine inadequate response adequate trial combine treatment . Pregnancy , lactation ; woman childbearing potential , use effective birth control method . Current cognitivebehavioral therapy . Any psychotherapy initiate within 3 month begin study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>trauma</keyword>
	<keyword>anxiety disorder</keyword>
	<keyword>medication</keyword>
	<keyword>sertraline</keyword>
	<keyword>mirtazapine</keyword>
	<keyword>pharmacotherapy</keyword>
</DOC>